External validation of nomograms for prediction of progression-free survival and liver toxicity in patients with advanced renal cell carcinoma treated with pazopanib

被引：0
|
作者：
Yasuyoshi Okamura
Nobuyuki Hinata
Tomoaki Terakawa
Junya Furukawa
Kenichi Harada
Yuzo Nakano
Ichiro Nakamura
Takaaki Inoue
Takayoshi Ogawa
Masato Fujisawa
机构：
[1] Kobe University Graduate School of Medicine,Department of Urology
[2] Kobe City Medical Center West Hospital,Department of Urology, Kobe City Hospital Organization
[3] Hyogo Cancer Center,Department of Urology
[4] Himeji Red Cross Hospital,Department of Urology
来源：
International Journal of Clinical Oncology | 2019年 / 24卷
关键词：
Renal cell carcinoma; Pazopanib; Nomogram; Validation; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：698 / 705
页数：7
相关论文
共 50 条
  • [1] External validation of nomograms for prediction of progression-free survival and liver toxicity in patients with advanced renal cell carcinoma treated with pazopanib
    Okamura, Yasuyoshi
    Hinata, Nobuyuki
    Terakawa, Tomoaki
    Furukawa, Junya
    Harada, Kenichi
    Nakano, Yuzo
    Nakamura, Ichiro
    Inoue, Takaaki
    Ogawa, Takayoshi
    Fujisawa, Masato
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (06) : 698 - 705
  • [2] Development and validation of a prognostic nomogram for progression-free survival in patients with advanced renal cell carcinoma treated with pazopanib
    Kattan, Michael W.
    Sternberg, Cora N.
    Mehmud, Faisal
    Bhatt, Kamal
    McCann, Lauren
    Motzer, Robert J.
    [J]. ONKOUROLOGIYA, 2015, 11 (04): : 16 - 23
  • [3] Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib
    Kattan, Michael W.
    Sternberg, Cora N.
    Mehmud, Faisal
    Bhatt, Kamal
    McCann, Lauren
    Motzer, Robert J.
    [J]. ONCOLOGY, 2015, 89 (04) : 235 - 241
  • [4] Development and validation of a prognostic nomogram for progression-free and overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib.
    Kattan, Michael W.
    Sternberg, Cora N.
    Mehmud, Faisal
    Bhatt, Kamalnayan
    Chakrabarti, Debasis
    McCann, Lauren
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Nexavar® improves progression-free survival of patients with advanced renal cell carcinoma
    Schäfer, H
    [J]. ONKOLOGIE, 2006, 29 (05): : 233 - 233
  • [6] Cardiovascular Comorbidities for Prediction of Progression-Free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib
    Szmit, Sebastian
    Zaborowska, Magdalena
    Wasko-Grabowska, Anna
    Zolnierek, Jakub
    Nurzynski, Pawel
    Filipiak, Krzysztof J.
    Opolski, Grzegorz
    Szczylik, Cezary
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (06): : 468 - 476
  • [7] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [8] LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY
    Lim, F. L.
    Shamash, J.
    Wilson, P.
    Powles, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 290 - 290
  • [9] Development of a nomogram to predict progression-free survival in patients with locally advanced renal cell carcinoma
    Xiao, Ruo-Tao
    Liu, Cheng
    Yang, Bin
    He, Wei
    Xu, Chu-Xiao
    Chen, Zhi-Gang
    Ma, Lu-Lin
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (22) : 2765 - 2767
  • [10] Development of a nomogram to predict progression-free survival in patients with locally advanced renal cell carcinoma
    Ruo-Tao Xiao
    Cheng Liu
    Bin Yang
    Wei He
    Chu-Xiao Xu
    Zhi-Gang Chen
    Lu-Lin Ma
    [J]. 中华医学杂志(英文版), 2021, 134 (22) : 2765 - 2767
12345